Life Sciences

Subscribe to Life Sciences

The PIPE market has proven to be resilient during times of stress.  In 2023, issuers raised over $33.8 billion in 809 PIPE transactions according to PrivateRaise.  This is considerably less than in 2021 during which issuers raised over $108.8 billion.  However, PIPE transaction activity has accelerated during the first five months of 2024.  Between…

Thursday, October 22, 2020
1:00pm – 2:00pm EDT
Register here.

Many companies are seeking alternatives to the traditional IPO, and considering merging into a SPAC, or a reverse merger. For life sciences companies, reverse merger transactions have become a popular alternative approach to going public. Merging into a public life sciences company that has…

The National Center of the Middle Market (NCMM) conducted a survey from March 12-23, 2020 of 400 strategic decision makers from life sciences companies in the United States and Canada. The report noted middle market life sciences companies, which include companies with annual revenues between $10 million and $1 billion, have experienced robust growth. Between…

CBInsights recently hosted a webcast, The State of Healthcare Q2 2020. Capital raising by companies in the global healthcare sector yielded a historic high of $18.1 billion in the second quarter of 2020, and deal volume rose 6% quarter-over-quarter. Total funding was boosted by six mega-rounds, or capital raises over $100 million, in the regenerative…

Sunday, July 19, 2020
9:00 a.m. – 10:00 a.m. EDT
4:00 p.m. – 5:00 p.m. Israel Time
Register here

Join Mayer Brown and PwC for a webinar on Life Sciences IPOs.  Panelists will discuss the pre-IPO and IPO markets and IPO preparedness, among other topics. CEO and Co-Founder of InMode, Moshe Mizrahy, will join our…

On June 10, 2020, the US Court of Appeals for the Ninth Circuit affirmed the dismissal of a putative securities fraud class action against Endologix, Inc., a medical device company, on the grounds that the shareholder’s core theory of liability had “no basis in logic or common experience.” In that case, Nguyen v. Endologix, Inc.,…

During the first quarter of 2020, venture funding levels in the global healthcare and life sciences sector has increased 4% by dollars raised, quarter-over-quarter, despite the turbulent COVID-19 environment. According to a recent CB Insights report, healthcare companies raised $14.6 billion this past quarter in 1,156 deals. Deal volume decreased 6% quarter-over-quarter. The inverse…

March 25, 2020
1:00 – 2:00 PM ET
Register here.

The last few years have seen a dramatic rise in the number of securities class-action cases involving initial public offerings, and this has affected D&O coverage and the costs associated with D&O insurance.

During this webcast, Mike Ferraro and Yelena Dunaevsky from Woodruff Sawyer…